Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,427,642
-$1,132,214 QoQ
Shares Held
250,025
-45.9% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 216 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $412,638,399 across 27 Biotechnology names. ANNX ranks #23 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
163,963 | $102,237,489 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
655,454 | $51,970,947 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,241,556 | $41,455,554 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
2,066,356 | $34,962,743 | |
| 5 | EXEL |
Exelixis, Inc.
|
578,873 | $31,496,479 | |
| 6 | BNTX |
BioNTech SE
|
243,422 | $22,650,417 | |
| 7 | ABSI |
Absci Corp
|
1,602,916 | $18,577,796 | |
| 8 | ARGX |
Argenx SE
|
18,797 | $17,439,292 |
All Filings in ANNX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,427,642 | 250,025 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,559,856 | 462,068 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||